Nano-delivery of DsiRNAs results in improved gene silencing and anticancer activity

Liu X, Liu C, et al. (2014) Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system. Nanomedicine, 10(8):1627–1636.

Citation summary: Find out how a dendrimer-based, targeted nano-delivery system that uses Dicer Substrate RNAs (DsiRNAs) leads to improved gene silencing and anticancer activity in prostate cancer models in vitro and in vivo.

Mar 23, 2015

Revised/updated Oct 7, 2015

Liu and colleagues have developed an siRNA delivery method that addresses 2 major challenges of using RNA interference for treating diseases: increasing siRNA potency and providing more targeted delivery. Working with in vitro and in vivo model systems for prostate cancer, the scientists used a dendrimer-based, targeted nano-delivery system to transport Dicer Substrate RNAs (DsiRNAs) into PC-3 cells and nude mice bearing PC-3 prostate cancer xenografts. Coupling this delivery mechanism with DsiRNAs resulted in a much greater RNAi response and, thus, improved therapeutic efficacy, than when conventional siRNAs were used. Further decoration of the DsiRNA/dendrimer complexes with a peptide that simultaneously promotes cancer cell targeting and penetration, led to improved gene silencing and anticancer activity in prostate cancer models in vitro and in vivo.

Your Advocate for the Genomics Age